Drug
Biib147
Biib147: highest development phase Phase 1/2, developed by Biogen. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- Biogen
Trials
| Drug | Phase | Indication |
|---|---|---|
| BIIB147 NCT07855211 | Phase 1/2 | Amyotrophic Lateral Sclerosis |
Latest
No recent events.
Follow Biib147 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.